What is the market doing?
What the tape says about INDV
Indivior Pharmaceuticals, Inc. is +62% over the past year while the S&P 500 is +23%: 40 points ahead of the market.
+62%
1-year return · S&P 500 +23%
- vs 200-day average
- +3.2%
vs 200-day average · close to trend
- RSI (14)
- 27
RSI (14) · oversold, sold harder than it has been bought
- Below its 52-week high
- −14%
Below its 52-week high
Details›
- Last close2026-08-26
- $35.81
- 1 monthS&P 500 +3.7%
- −12%
- 1 yearS&P 500 +23%
- +62%
- 5 yearsS&P 500 +87%
- +217%
- vs 50-day average$38.55
- −7.1%
- 52-week high
- $41.47
- 52-week low
- $22.00
- Annualised volatility
- 49%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- $204K
| Year | Return |
|---|---|
| 2026 (year to date) | −0.20% |
| 2025 | +189% |
| 2024 | −19% |
| 2023 | −30% |
| 2022 | +26% |
| 2021 | +135% |
| 2020 | +182% |
| 2019 | −61% |
| 2018 | −75% |
| 2017 | +55% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 6 of 10 | +3.8% |
| Feb | 10 | 5 of 10 | +0.24% |
| Mar | 10 | 4 of 10 | −1.3% |
| Apr | 10 | 8 of 10 | +2.8% |
| May | 10 | 8 of 10 | +5.6% |
| Jun | 10 | 4 of 10 | +3.6% |
| Jul | 11 | 7 of 11 | +13% |
| Aug | 11 | 6 of 11 | +0.54% |
| Sep | 10 | 2 of 10 | −11% |
| Oct | 10 | 4 of 10 | +4.4% |
| Nov | 10 | 6 of 10 | −0.94% |
| Dec | 10 | 7 of 10 | +2.8% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Drug Manufacturers - Specialty & Generic
Ranks #23 of 28 by Smart Score